Compare GXO & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GXO | STVN |
|---|---|---|
| Founded | 2021 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Transportation Services | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.7B |
| IPO Year | 2021 | 2021 |
| Metric | GXO | STVN |
|---|---|---|
| Price | $45.25 | $21.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | ★ $67.91 | $25.67 |
| AVG Volume (30 Days) | ★ 1.2M | 300.2K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $13,178,000,000.00 | N/A |
| Revenue This Year | $6.81 | $9.67 |
| Revenue Next Year | $5.95 | $9.99 |
| P/E Ratio | $176.68 | ★ $27.15 |
| Revenue Growth | ★ 12.55 | N/A |
| 52 Week Low | $43.61 | $12.89 |
| 52 Week High | $66.85 | $27.99 |
| Indicator | GXO | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 43.25 | 49.80 |
| Support Level | N/A | $20.17 |
| Resistance Level | $48.40 | $22.00 |
| Average True Range (ATR) | 1.40 | 0.92 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 32.72 | 39.80 |
GXO Logistics Inc is a contract logistics company. Its revenue is diversified across numerous verticals and customers, including many multinational corporations. It provides warehousing and distribution, order fulfillment, e-commerce, reverse logistics, and other supply chain services differentiated by its ability to deliver technology-enabled, customized solutions at scale. Geographically, it generates revenue from the United Kingdom, the United States, the Netherlands, France, Spain, Italy, and other countries, and derives the majority of its revenue from the United Kingdom.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.